Bonnie Ky, MD, MSCE
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
11-105 Smilow Center for Translational Research
3400 Civic Center Boulevard
Philadelphia, PA 19104
11-105 Smilow Center for Translational Research
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-573-6606
Fax: 215-746-7415
Fax: 215-746-7415
Email:
bonnie.ky@uphs.upenn.edu
bonnie.ky@uphs.upenn.edu
Graduate Group Affiliations
Publications
Education:
BS (Chemical Engineering )
Massachusetts Institute of Technology, 1995.
MD (Medicine)
University of Pennsylvania, 2001.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2009.
BS (Chemical Engineering )
Massachusetts Institute of Technology, 1995.
MD (Medicine)
University of Pennsylvania, 2001.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2009.
Post-Graduate Training
Intern in Medicine, Hospital of the University of Pennsylvania, Philadelphia, 2001-2002.
Resident in Medicine, Hospital of the University of Pennsylvania, Philadelphia, 2002-2004.
Fellowship in Cardiology, Hospital of the University of Pennsylvania, Philadelphia, 2004-2007.
Fellowship, Cardiology Noninvasive Research, Hospital of the University of Pennsylvania, Philadelphia, 2007-2008.
Intern in Medicine, Hospital of the University of Pennsylvania, Philadelphia, 2001-2002.
Resident in Medicine, Hospital of the University of Pennsylvania, Philadelphia, 2002-2004.
Fellowship in Cardiology, Hospital of the University of Pennsylvania, Philadelphia, 2004-2007.
Fellowship, Cardiology Noninvasive Research, Hospital of the University of Pennsylvania, Philadelphia, 2007-2008.
Certifications
Internal Medicine, American Board of Internal Medicine, 2004.
Cardiovascular Medicine, American Board of Internal Medicine, 2007.
Level II Nuclear Cardiology, Certification Board of Nuclear Cardiology, 2007.
Level III Echocardiography, National Board of Echocardiography, 2007.
Permanent linkInternal Medicine, American Board of Internal Medicine, 2004.
Cardiovascular Medicine, American Board of Internal Medicine, 2007.
Level II Nuclear Cardiology, Certification Board of Nuclear Cardiology, 2007.
Level III Echocardiography, National Board of Echocardiography, 2007.
Description of Clinical Expertise
echocardiography, cancer therapy cardiotoxicityDescription of Research Expertise
neuregulin signaling, vascular growth factor signaling, cardiac remodeling, heart failure, cancer therapy cardiotoxicity, translational researchSelected Publications
Christian JB, Finkle JK, Ky B, Douglas PS, Gutstein DE, Hockings PD, Lainee P, Lenihan DJ, Mason JW, Sager PT, Todaro TG, Hicks KA, Ko H, Lindenfeld J, Michelson EL, Milligan J, Munley JY, Taichlen JS, Shahlaee A, Strnadova C, Ye B, Turner JR: Cardiac Imaging Approaches to Evaluate Drug-Induced Myocardial Dysfunction. American Heart Journal 164(6): 846-55, December 2012.Sawaya H, Sebag I, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver J, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M: Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated with Anthracyclines, Taxanes, and Trastuzumab. Circulation Cardiovascular Imaging 5(5): 596-603, September 2012.
French B, Saha-Chaudhuri P, Ky B, Cappola TP, Heagerty PJ: Development and Evaluation of Multi-Marker Risk Scores for Clinical Prognosis. Statistical Methods in Medical Research July 2012 Notes: Epub ahead of print.
Ky B, Plappert T, Kirkpatrick J, Silvestry FE, Ferrari VA, Keane MG, Wiegers SE, Chirinos JA, St John Sutton M: Left Ventricular Remodeling in Human Heart Failure: Quantitative Echocardiographic Assessment of 1,794 Patients. Echocardiography 29(7): 758-65, April 2012.
Ky B, French B, Levy WC, Sweitzer NK, Fang JC, Wu AHB, Goldberg LR, Jessup M, Cappola TP: Multiple Biomarkers for Risk Prediction in Chronic Heart Failure. Circulation. Heart Failure 5(2): 183-90, March 2012.
Flory JH, Ky B, Haynes K, M Brunelli S, Munson J, Rowan C, Strom BL, Hennessy S: Observational Cohort Study of the Safety of Digoxin Use in Women with Heart Failure. BMJ open 2(2): e000888, 2012.
Ogbara J, Logani S, Ky B, Chirinos JA, Silvestry FE, Eberman K, Moss JD, Ferrari VA, Keane MG, St John Sutton M, Wiegers SE, Kirkpatrick JN: The Utility of Prescreening Transesophageal Echocardiograms: a Prospective Study. Echocardiography 28(7): 767-73, August 2011.
Ky B, French B, Ruparel K, Sweitzer NK, Fang JC, Levy WC, Sawyer DB, Cappola TP: The Vascular Marker Soluble FMS-like Tyrosine Kinase 1 Is Associated with Disease Severity and Adverse Outcomes in Chronic Heart Failure. Journal of the American College of Cardiology 58(4): 386-94, July 2011.
Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, Gosavi S, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M: Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients. The American Journal of Cardiology 107(9): 1375-80, May 2011.
Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, Dries DL, Tang WHW, Wu AHB, Fang JC, Boxer R, Sweitzer NK, Levy WC, Goldberg LR, Jessup M, Cappola TP: High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure. Circulation. Heart Failure 4(2): 180-7, March 2011.